Hepatitis c virus network based classification of hepatocellular cirrhosis and carcinoma

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Huang, Tao ^b,c,d   Wang, Junjie ^i,j   Cai, Yu Dong ^a,e,n   Yu, Hanry ^{f,g,h,i,j,k,l,m}   Chou, Kuo Chen ⁿ  

^a SHANGHAI UNIVERSITY   (China)

^b Chinese Academy of Sciences   (China)

^c SHANGHAI CENTER FOR BIOINFORMATION TECHNOLOGY   (China)

^d UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^e FUDAN UNIVERSITY   (China)

^f NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^g INSTITUTE OF BIOENGINEERING AND NANOTECHNOLOGY   (Singapore)

^h NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

ⁱ NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^j SINGAPORE MIT ALLIANCE   (Singapore)

^k NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^l SINGAPORE MIT ALLIANCE FOR RESEARCH AND TECHNOLOGY   (Singapore)

^m USA   (United States)

ⁿ GORDON LIFE SCIENCE INSTITUTE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; VIRUS PROTEIN;

ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE MARKER; GENE EXPRESSION PROFILING; GENE TARGETING; GENETIC SELECTION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MATHEMATICAL MODEL; RISK FACTOR; TUMOR GENE; VALIDATION PROCESS; CLASSIFICATION; DIFFERENTIAL DIAGNOSIS; GENETICS; HOST PATHOGEN INTERACTION; LIVER; LIVER TUMOR; METABOLISM; PATHOLOGY; PROTEIN ANALYSIS; PROTEIN PROTEIN INTERACTION; VIROLOGY; VIRUS GENE;

HEPATITIS C VIRUS;

BIOLOGICAL MARKERS; CARCINOMA, HEPATOCELLULAR; DIAGNOSIS, DIFFERENTIAL; GENES, VIRAL; HEPACIVIRUS; HEPATITIS C; HOST-PATHOGEN INTERACTIONS; HUMANS; LIVER; LIVER CIRRHOSIS; LIVER NEOPLASMS; PROTEIN INTERACTION MAPPING; PROTEIN INTERACTION MAPS; RISK FACTORS;

EID: 84859499974     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0034460     Document Type: Article

References (85)

1. Tsukuma H, Hiyama T, Tanaka S, Nakao M, Yabuuchi T, et al. (1993) Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med 328: 1797-1801.
2. El-Serag HB, Mason AC, (1999) Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 340: 745-750.
3. Tagger A, Donato F, Ribero ML, Chiesa R, Portera G, et al. (1999) Case-control study on hepatitis C virus (HCV) as a risk factor for hepatocellular carcinoma: the role of HCV genotypes and the synergism with hepatitis B virus and alcohol. Brescia HCC Study. Int J Cancer 81: 695-699.
4. Farazi PA, DePinho RA, (2006) Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer 6: 674-687.
5. De Giorgi V, Monaco A, Worchech A, Tornesello M, Izzo F, et al. (2009) Gene profiling, biomarkers and pathways characterizing HCV-related hepatocellular carcinoma. Journal of translational medicine 7: 85.
6. El-Serag HB, Marrero JA, Rudolph L, Reddy KR, (2008) Diagnosis and treatment of hepatocellular carcinoma. Gastroenterology 134: 1752-1763.
7. Hoshida Y, Villanueva A, Kobayashi M, Peix J, Chiang DY, et al. (2008) Gene expression in fixed tissues and outcome in hepatocellular carcinoma. N Engl J Med 359: 1995-2004.
8. Shang S, Plymoth A, Ge S, Feng Z, Rosen HR, et al. (2011) Identification of osteopontin as a novel marker for early hepatocellular carcinoma. Hepatology.
9. Zhang Z, Xu L, Wang Z, (2011) Screening serum biomarkers for early primary hepatocellular carcinoma using a phage display technique. J Clin Lab Anal 25: 402-408.
10. Kudo M, (2011) Future treatment option for hepatocellular carcinoma: a focus on brivanib. Dig Dis 29: 316-320.
11. Lemmer ER, Friedman SL, Llovet JM, (2006) Molecular diagnosis of chronic liver disease and hepatocellular carcinoma: the potential of gene expression profiling. Seminars in liver disease 26: 373-384.
12. Wang F, Anderson PW, Salem N, Kuang Y, Tennant BC, et al. (2007) Gene expression studies of hepatitis virus-induced woodchuck hepatocellular carcinoma in correlation with human results. International journal of oncology 30: 33-44.
13. Zhang LH, Ji JF, (2005) Molecular profiling of hepatocellular carcinomas by cDNA microarray. World journal of gastroenterology: WJG 11: 463-468.
14. Michiels S, Koscielny S, Hill C, (2005) Prediction of cancer outcome with microarrays: a multiple random validation strategy. Lancet 365: 488-492.
15. Abraham G, Kowalczyk A, Loi S, Haviv I, Zobel J, (2010) Prediction of breast cancer prognosis using gene set statistics provides signature stability and biological context. BMC Bioinformatics 11: 277.
16. Chou KC, (2011) Some remarks on protein attribute prediction and pseudo amino acid composition (50th Anniversary Year Review). Journal of Theoretical Biology 273: 236-247.
17. Mas VR, Maluf DG, Archer KJ, Yanek K, Kong X, et al. (2009) Genes involved in viral carcinogenesis and tumor initiation in hepatitis C virus-induced hepatocellular carcinoma. Mol Med 15: 85-94.
18. Huber W, Gentleman R, (2004) matchprobes: a Bioconductor package for the sequence-matching of microarray probe elements. Bioinformatics 20: 1651-1652.
19. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, et al. (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4: 249-264.
20. Bolstad BM, Irizarry RA, Astrand M, Speed TP, (2003) A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19: 185-193.
21. Chou KC, (2009) Pseudo amino acid composition and its applications in bioinformatics, proteomics and system biology. Current Proteomics 6: 262-274.
22. de Chassey B, Navratil V, Tafforeau L, Hiet MS, Aublin-Gex A, et al. (2008) Hepatitis C virus infection protein network. Mol Syst Biol 4: 230.
23. Jensen LJ, Kuhn M, Stark M, Chaffron S, Creevey C, et al. (2009) STRING 8-a global view on proteins and their functional interactions in 630 organisms. Nucleic Acids Res 37: D412-416.
24. Dijkstra EW, (1959) A note on two problems in connexion with graphs. Numerische Mathematik 1: 269-271.
25. Chartrand G, Oellermann OR, (1992) Applied and Algorithmic Graph Theory: Mcgraw-Hill College.
26. Cormen TH, Leiserson CE, R.L. R, Stein C, (2001) Introduction to Algorithms (second ed.): MIT press and Mcgraw-Hill.
27. Peng H, Long F, Ding C, (2005) Feature selection based on mutual information: criteria of max-dependency, max-relevance, and min-redundancy. IEEE Trans Pattern Anal Mach Intell 27: 1226-1238.
28. Cover TM, Hart PE, (1967) Nearest Neighbor Pattern Classification. Ieee Transactions on Information Theory 13: 21.
29. Friedman JH, Baskett F, Shustek LJ, (1975) An algorithm for finding nearest neighbors. IEEE Transaction on Information Theory C-24: 1000-1006.
30. Denoeux T, (1995) A k-nearest neighbor classification rule based on Dempster-Shafer theory. IEEE Transactions on Systems, Man and Cybernetics 25: 804-813.
31. Chou KC, Shen HB, (2007) Review: Recent progresses in protein subcellular location prediction. Analytical Biochemistry 370: 1-16.
32. Hu L, Huang T, Shi X, Lu WC, Cai YD, et al. (2011) Predicting functions of proteins in mouse based on weighted protein-protein interaction network and protein hybrid properties PLoS ONE 6: e14556.
33. Hu LL, Huang T, Cai YD, Chou KC, (2011) Prediction of Body Fluids where Proteins are Secreted into Based on Protein Interaction Network. PLoS One 6: e22989.
34. Huang T, Chen L, Cai YD, Chou KC, (2011) Classification and analysis of regulatory pathways using graph property, biochemical and physicochemical property, and functional property. PLoS ONE 6: e25297.
35. Huang T, Niu S, Xu Z, Huang Y, Kong X, et al. (2011) Predicting Transcriptional Activity of Multiple Site p53 Mutants Based on Hybrid Properties. PLoS ONE 6: e22940.
36. Wang P, Hu L, Liu G, Jiang N, Chen X, et al. (2011) Prediction of antimicrobial peptides based on sequence alignment and feature selection methods. PLoS ONE 6: e18476.
37. Chou KC, Wu ZC, Xiao X, (2012) iLoc-Hum: Using accumulation-label scale to predict subcellular locations of human proteins with both single and multiple sites. Molecular Biosystems 8: 629-641.
38. Wu ZC, Xiao X, Chou KC, (2012) iLoc-Gpos: A Multi-Layer Classifier for Predicting the Subcellular Localization of Singleplex and Multiplex Gram-Positive Bacterial Proteins. Protein & Peptide Letters 19: 4-14.
39. Xiao X, Wang P, Chou KC, (2011) GPCR-2L: Predicting G protein-coupled receptors and their types by hybridizing two different modes of pseudo amino acid compositions. Molecular Biosystems 7: 911-919.
40. Wang P, Xiao X, Chou KC, (2011) NR-2L: A Two-Level Predictor for Identifying Nuclear Receptor Subfamilies Based on Sequence-Derived Features. PLoS ONE 6: e23505.
41. Xiao X, Wu ZC, Chou KC, (2011) A multi-label classifier for predicting the subcellular localization of gram-negative bacterial proteins with both single and multiple sites. PLoS ONE 6: e20592.
42. Chou KC, Wu ZC, Xiao X, (2011) iLoc-Euk: A Multi-Label Classifier for Predicting the Subcellular Localization of Singleplex and Multiplex Eukaryotic Proteins. PLoS One 6: e18258.
43. Chou KC, Zhang CT, (1995) Review: Prediction of protein structural classes. Critical Reviews in Biochemistry and Molecular Biology 30: 275-349.
44. Mahalanobis PC, (1936) On the generalized distance in statistics. Proc Natl Inst Sci India 2: 49-55.
45. Pillai KCS, (1985) Mahalanobis D2. In: Kotz S, Johnson NL, editors. Encyclopedia of Statistical Sciences New York John Wiley & Sons pp. 176-181 This reference also presents a brief biography of Mahalanobis who was a man of great originality and who made considerable contributions to statistics.
46. Chou KC, (1995) A novel approach to predicting protein structural classes in a (20-1)-D amino acid composition space. Proteins: Structure, Function & Genetics 21: 319-344.
47. Chou KC, Shen HB, (2008) Cell-PLoc: A package of Web servers for predicting subcellular localization of proteins in various organisms (updated version: Cell-PLoc 2.0: An improved package of web-servers for predicting subcellular localization of proteins in various organisms, Natural Science, 2010, 2, 1090-1103). Nature Protocols 3: 153-162.
48. Huang T, Shi XH, Wang P, He Z, Feng KY, et al. (2010) Analysis and prediction of the metabolic stability of proteins based on their sequential features, subcellular locations and interaction networks. PLoS ONE 5: e10972.
49. Hu LL, Chen C, Huang T, Cai YD, Chou KC, (2011) Predicting biological functions of compounds based on chemical-chemical interactions. PLoS ONE 6: e29491.
50. Mohabatkar H, Mohammad Beigi M, Esmaeili A, (2011) Prediction of GABA(A) receptor proteins using the concept of Chou's pseudo-amino acid composition and support vector machine. Journal of Theoretical Biology 281: 18-23.
51. Esmaeili M, Mohabatkar H, Mohsenzadeh S, (2010) Using the concept of Chou's pseudo amino acid composition for risk type prediction of human papillomaviruses. Journal of Theoretical Biology 263: 203-209.
52. Lin WZ, Fang JA, Xiao X, Chou KC, (2011) iDNA-Prot: Identification of DNA Binding Proteins Using Random Forest with Grey Model. PLoS ONE 6: e24756.
53. Nanni L, Lumini A, (2009) A Further Step Toward an Optimal Ensemble of Classifiers for Peptide Classification, a Case Study: HIV Protease. Protein & Peptide Letters 16: 163-167.
54. Xiao X, Wu ZC, Chou KC, (2011) iLoc-Virus: A multi-label learning classifier for identifying the subcellular localization of virus proteins with both single and multiple sites. Journal of Theoretical Biology 284: 42-51.
55. Wu ZC, Xiao X, Chou KC, (2011) iLoc-Plant: a multi-label classifier for predicting the subcellular localization of plant proteins with both single and multiple sites. Molecular BioSystems 7: 3287-3297.
56. Huang T, Cui W, Hu L, Feng K, Li YX, et al. (2009) Prediction of pharmacological and xenobiotic responses to drugs based on time course gene expression profiles. PLoS One 4: e8126.
57. He Z, Zhang J, Shi XH, Hu LL, Kong X, et al. (2010) Predicting drug-target interaction networks based on functional groups and biological features. PLoS ONE 5: e9603.
58. Frick DN, (2007) The hepatitis C virus NS3 protein: a model RNA helicase and potential drug target. Curr Issues Mol Biol 9: 1-20.
59. Cook GA, Stefer S, Opella SJ, (2011) Expression and purification of the membrane protein p7 from hepatitis C virus. Biopolymers 96: 32-40.
60. Walker MP, Appleby TC, Zhong W, Lau JY, Hong Z, (2003) Hepatitis C virus therapies: current treatments, targets and future perspectives. Antivir Chem Chemother 14: 1-21.
61. Deng L, Nagano-Fujii M, Tanaka M, Nomura-Takigawa Y, Ikeda M, et al. (2006) NS3 protein of Hepatitis C virus associates with the tumour suppressor p53 and inhibits its function in an NS3 sequence-dependent manner. J Gen Virol 87: 1703-1713.
62. Chen SH, Tan SL, (2005) Discovery of small-molecule inhibitors of HCV NS3-4A protease as potential therapeutic agents against HCV infection. Curr Med Chem 12: 2317-2342.
63. Gao M, Nettles RE, Belema M, Snyder LB, Nguyen VN, et al. (2010) Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect. Nature 465: 96-100.
64. Strosberg AD, Kota S, Takahashi V, Snyder JK, Mousseau G, (2010) Core as a Novel Viral Target for Hepatitis C Drugs. Viruses 2: 1734-1751.
65. Mousseau G, Kota S, Takahashi V, Frick DN, Strosberg AD, (2011) Dimerization-driven interaction of hepatitis C virus core protein with NS3 helicase. J Gen Virol 92: 101-111.
66. Su WH, Chao CC, Yeh SH, Chen DS, Chen PJ, et al. (2007) OncoDB.HCC: an integrated oncogenomic database of hepatocellular carcinoma revealed aberrant cancer target genes and loci. Nucleic Acids Res 35: D727-731.
67. Carmona-Saez P, Chagoyen M, Tirado F, Carazo JM, Pascual-Montano A, (2007) GENECODIS: a web-based tool for finding significant concurrent annotations in gene lists. Genome Biol 8: R3.
68. Nogales-Cadenas R, Carmona-Saez P, Vazquez M, Vicente C, Yang X, et al. (2009) GeneCodis: interpreting gene lists through enrichment analysis and integration of diverse biological information. Nucleic Acids Res 37: W317-322.
69. Song EL, Hou YP, Yu SP, Chen SG, Huang JT, et al. (2011) EFEMP1 expression promotes angiogenesis and accelerates the growth of cervical cancer in vivo. Gynecol Oncol 121: 174-180.
70. Nomoto S, Kanda M, Okamura Y, Nishikawa Y, Qiyong L, et al. (2010) Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis. Ann Surg Oncol 17: 923-932.
71. Kiernan AE, Cordes R, Kopan R, Gossler A, Gridley T, (2005) The Notch ligands DLL1 and JAG2 act synergistically to regulate hair cell development in the mammalian inner ear. Development 132: 4353-4362.
72. Pietras A, von Stedingk K, Lindgren D, Pahlman S, Axelson H, (2011) JAG2 Induction in Hypoxic Tumor Cells Alters Notch Signaling and Enhances Endothelial Cell Tube Formation. Mol Cancer Res 9: 626-636.
73. Casey LM, Lan Y, Cho ES, Maltby KM, Gridley T, et al. (2006) Jag2-Notch1 signaling regulates oral epithelial differentiation and palate development. Dev Dyn 235: 1830-1844.
74. Cubas R, Zhang S, Li M, Chen C, Yao Q, (2010) Trop2 expression contributes to tumor pathogenesis by activating the ERK MAPK pathway. Mol Cancer 9: 253.
75. Wang YH, Huang ML, (2010) Organogenesis and tumorigenesis: insight from the JAK/STAT pathway in the Drosophila eye. Dev Dyn 239: 2522-2533.
76. Silva CM, (2004) Role of STATs as downstream signal transducers in Src family kinase-mediated tumorigenesis. Oncogene 23: 8017-8023.
77. Garbi N, Tanaka S, Momburg F, Hammerling GJ, (2006) Impaired assembly of the major histocompatibility complex class I peptide-loading complex in mice deficient in the oxidoreductase ERp57. Nat Immunol 7: 93-102.
78. Shim EK, Jung SH, Lee JR, (2011) Role of two adaptor molecules SLP-76 and LAT in the PI3K signaling pathway in activated T cells. J Immunol 186: 2926-2935.
79. Oppmann B, Lesley R, Blom B, Timans JC, Xu Y, et al. (2000) Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13: 715-725.
80. Parham C, Chirica M, Timans J, Vaisberg E, Travis M, et al. (2002) A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R. J Immunol 168: 5699-5708.
81. Piskin G, Sylva-Steenland RM, Bos JD, Teunissen MB, (2006) In vitro and in situ expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: enhanced expression in psoriatic skin. J Immunol 176: 1908-1915.
82. Wu TT, Castle JD, (1998) Tyrosine phosphorylation of selected secretory carrier membrane proteins, SCAMP1 and SCAMP3, and association with the EGF receptor. Mol Biol Cell 9: 1661-1674.
83. Zhao C, Denison C, Huibregtse JM, Gygi S, Krug RM, (2005) Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways. Proc Natl Acad Sci U S A 102: 10200-10205.
84. Lenschow DJ, Giannakopoulos NV, Gunn LJ, Johnston C, O'Guin AK, et al. (2005) Identification of interferon-stimulated gene 15 as an antiviral molecule during Sindbis virus infection in vivo. J Virol 79: 13974-13983.
85. Romero-Gomez M, (2006) Insulin resistance and hepatitis C. World J Gastroenterol 12: 7075-7080.